PHIPO January 2024 release

This release contains the following changes since the previous release (30 November 2023).

New terms

resistance to pyrisoxazole (PHIPO:0001388) (#419)
sensitive to pyrisoxazole (PHIPO:0001389) (#419)
normal growth on pyrisoxazole (PHIPO:0001390) (#419)
resistance to metconazole (PHIPO:0001391) (#419)
sensitive to metconazole (PHIPO:0001392) (#419)
normal growth on metconazole (PHIPO:0001393) (#419)
resistance to trifloxystrobin (PHIPO:0001394) (#419)
sensitive to trifloxystrobin (PHIPO:0001395) (#419)
normal growth on trifloxystrobin (PHIPO:0001396) (#419)
sensitive to cell wall stress (PHIPO:0001397) (#427)
sensitive to oxidative stress (PHIPO:0001398) (#428)
resistance to flusilazole (PHIPO:0001399) (#419)
sensitive to flusilazole (PHIPO:0001400) (#419)
normal growth on flusilazole (PHIPO:0001401) (#419)
resistance to mandipropamid (PHIPO:0001402) (#419)
sensitive to mandipropamid (PHIPO:0001403) (#419)
normal growth on mandipropamid (PHIPO:0001404) (#419)
resistance to dimethomorph (PHIPO:0001405) (#419)
sensitive to dimethomorph (PHIPO:0001406) (#419)
normal growth on dimethomorph (PHIPO:0001407) (#419)
resistance to iprovalicarb (PHIPO:0001408) (#419)
sensitive to iprovalicarb (PHIPO:0001409) (#419)
normal growth on iprovalicarb (PHIPO:0001410) (#419)

'sensitive to congo red' (PHIPO:0001021) has an additional parent term: 'sensitive to stress' (PHIPO:0001397) (#427)
'sensitive to hydrogen peroxide' (PHIPO:0000943) has an additional parent term: 'sensitive to oxidative stress' (PHIPO:0001398) (#428)

Full Changelog: v2023-11-30...v2024-01-31